Related Experiment Video
Updated: Jun 21, 2026
04:41
Treatment with Locking Intramedullary Nailing for Intertrochanteric Fracture of the Femur Utilizing a New Awl with a Distal Positioner
Published on: June 6, 2025
Patient experience with a new teriparatide delivery device
Robin K Dore1, Robert G Feldman, Kathleen A Taylor
1Robin K Dore MD, Inc., 18102 Irvine Boulevard, Suite 104, Tustin, CA 92780-3423, USA. rkdmail@sbcglobal.net
Current Medical Research and Opinion
|August 7, 2009
Summary
Patients found the new teriparatide delivery device easy to use, with most preferring it over the original. This study assessed the functionality and acceptability of the new device for osteoporosis treatment.
Area of Science:
- Osteoporosis management
- Drug delivery systems
- Patient-reported outcomes
Background:
- Teriparatide is a critical treatment for osteoporosis.
- Existing delivery devices may present challenges for patients.
- Optimizing drug delivery enhances patient adherence and treatment efficacy.
Purpose of the Study:
- To evaluate the functionality and patient acceptability of a novel teriparatide delivery device.
- To compare patient preference for the new device versus the original teriparatide delivery system.
- To identify common complaints and adverse events associated with the new teriparatide delivery device.
Main Methods:
- An eight-week, single-arm, multicenter, open-label clinical trial was conducted.
- Patients with osteoporosis received teriparatide 20 mcg/day via subcutaneous injection using the new device.
- Participants were stratified into Current Users (n=92) and Not Current Users (n=107) of the original device.
Main Results:
- The new teriparatide delivery device was found to be easy to use by 99.5% of patients.
- Common complaints included device size (4.0%) and lack of information on alcohol swabs (3.5%).
- Most current users (92%) preferred the new device over the original; 90% reported reduced reluctance to self-inject.
Conclusions:
- The new teriparatide delivery device demonstrates high ease of use and patient acceptability.
- Patient preference favors the new device, particularly among those with prior experience with teriparatide delivery systems.
- The findings support the successful implementation of this new device in osteoporosis therapy.
Related Concept Videos
01:28Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...